{"data":[{"accessionNo":"0002012383-26-002783","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2534789,"percentOfClass":5.5,"filedAt":"2026-07-29"},{"accessionNo":"0001104659-26-066339","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2026-05-21","reportingPerson":"Felix J. Baker","reportingCik":"0001087940","personType":"IN,HC","sharesOwned":3253341,"percentOfClass":7,"filedAt":"2026-05-26"},{"accessionNo":"0001104659-26-066339","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2026-05-21","reportingPerson":"Julian C. Baker","reportingCik":"0001087939","personType":"IN,HC","sharesOwned":3253341,"percentOfClass":7,"filedAt":"2026-05-26"},{"accessionNo":"0001104659-26-066339","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2026-05-21","reportingPerson":"Baker Bros. Advisors LP","reportingCik":"0001263508","personType":"IA,PN","sharesOwned":3231181,"percentOfClass":6.9,"filedAt":"2026-05-26"},{"accessionNo":"0001104659-26-066339","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2026-05-21","reportingPerson":"Baker Bros. Advisors (GP) LLC","reportingCik":"0001580575","personType":"HC,OO","sharesOwned":3231181,"percentOfClass":6.9,"filedAt":"2026-05-26"},{"accessionNo":"0001104659-26-066339","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2026-05-21","reportingPerson":"FBB3 LLC","reportingCik":"0001625395","personType":"OO","sharesOwned":7320,"percentOfClass":0.02,"filedAt":"2026-05-26"},{"accessionNo":"0000315066-26-001224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001730430","issuerName":"KINIKSA PHARMACEUTICALS INTERNATIONAL PL","ticker":"KNSA","cusip":"G52694109","securityClass":"CLASS A COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":6787700.23,"percentOfClass":14.8,"filedAt":"2026-05-06"},{"accessionNo":"0000315066-26-001224","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001730430","issuerName":"KINIKSA PHARMACEUTICALS INTERNATIONAL PL","ticker":"KNSA","cusip":"G52694109","securityClass":"CLASS A COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":6787700.23,"percentOfClass":14.8,"filedAt":"2026-05-06"},{"accessionNo":"0000102909-26-001633","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International Plc","ticker":"KNSA","cusip":"G52694109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27"},{"accessionNo":"0000315066-26-000640","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001730430","issuerName":"KINIKSA PHARMACEUTICALS INTERNATIONAL PL","ticker":"KNSA","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":4854354.23,"percentOfClass":10.6,"filedAt":"2026-03-06"},{"accessionNo":"0000315066-26-000640","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001730430","issuerName":"KINIKSA PHARMACEUTICALS INTERNATIONAL PL","ticker":"KNSA","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":4854354.23,"percentOfClass":10.6,"filedAt":"2026-03-06"},{"accessionNo":"0001104659-26-015194","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":null,"securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2025-12-31","reportingPerson":"David Rosen","reportingCik":null,"personType":"HC,IN","sharesOwned":3328653,"percentOfClass":7.37,"filedAt":"2026-02-13"},{"accessionNo":"0001104659-26-015194","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International, plc","ticker":"KNSA","cusip":null,"securityClass":"Class A Ordinary Shares, nominal value $0.000273235 per share","eventDate":"2025-12-31","reportingPerson":"Rubric Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3328653,"percentOfClass":7.37,"filedAt":"2026-02-13"},{"accessionNo":"0000102909-25-000265","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001730430","issuerName":"Kiniksa Pharmaceuticals International Plc","ticker":"KNSA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":3063135,"percentOfClass":7.04,"filedAt":"2025-10-31"}],"updatedAt":"2026-09-14T15:52:39.735Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}